Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis

被引:13
|
作者
Navaneethan, Udayakumar [1 ]
Venkatesh, Preethi G. K. [1 ]
Lashner, Bret A. [1 ]
Remzi, Feza H.
Shen, Bo [1 ]
Kiran, Ravi P.
机构
[1] Cleveland Clin, Inst Digest Dis, Dept Gastroenterol, Cleveland, OH 44106 USA
来源
JOURNAL OF CROHNS & COLITIS | 2012年 / 6卷 / 08期
关键词
Primary sclerosing cholangitis; Ulcerative colitis; Inflammatory bowel disease; Liver transplantation; Dysplasia; INFLAMMATORY-BOWEL-DISEASE; NATURAL-HISTORY; LOW-GRADE; PSC-IBD; DYSPLASIA; CANCER; RISK; CLASSIFICATION; SURVEILLANCE;
D O I
10.1016/j.crohns.2012.01.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: Surveillance for colon cancer is recommended in patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). It is unclear whether characteristics of colon neoplasia have changed over time. The aim of the study was to examine the temporal trends in colon neoplasia in patients with PSC and UC. Methods: A total of 167 patients followed up at our institution between 1985 and 2011, 55 of these with neoplasia detected on colonoscopic biopsy were identified. Characteristics of patients with colon neoplasia in PSC UC were studied for two different time periods: 1985-1998 (early cohort) compared to 1999-2011 (recent cohort). Results: The median age at diagnosis of colon neoplasms was 53 years (median IQR, 43-63). The baseline characteristics were similar in both cohorts. The colonic neoplasms that developed in PSC UC patients were spread throughout the colon on colonoscopy, while there was predominant right sided distribution on colectomy in both cohorts. (81.7% vs. 18.3%, p<0.001) Compared to the recent cohort, both the PSC (17 vs. 11 years, p=0.02) and UC duration (20 vs. 12 years, p=0.02) were longer in the early cohort. There were no differences in the grades and stages of cancer diagnosis. In addition, no differences in transplant-free survival or UC characteristics were revealed. Conclusions: With annual colonoscopic surveillance, dysplasia and cancer in patients with a combined diagnosis of PSC//UC is being diagnosed in patients with a shorter duration of these conditions. The nature and the location of neoplasia have, however, not changed. (c) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:845 / 851
页数:7
相关论文
共 50 条
  • [41] Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis
    Lepisto, Anna
    Kivisto, Sari
    Kivisaari, Leena
    Arola, Johanna
    Jarvinen, Heikki J.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (10) : 1169 - 1174
  • [42] Extracolonic and colonic cancer risk in patients with ulcerative colitis and primary sclerosing cholangitis
    Jelakovic, M.
    Brinar, M.
    Turk, N.
    Prijic, R.
    Krznaric, Z.
    Rustemovic, N.
    Cukovic-Cavka, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S464 - S464
  • [43] Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
    Pardi, DS
    Loftus, EV
    Kremers, WK
    Keach, J
    Lindor, KD
    GASTROENTEROLOGY, 2003, 124 (04) : 889 - 893
  • [44] Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis
    Anna Lepistö
    Sari Kivistö
    Leena Kivisaari
    Johanna Arola
    Heikki J. Järvinen
    International Journal of Colorectal Disease, 2009, 24 : 1169 - 1174
  • [45] The impact of severity of primary sclerosing cholangitis and clinical outcome in patients with Ulcerative Colitis
    Navaneethan, Udayakumar
    Venkatesh, Preethi G. K.
    Mukewar, Saurabh
    Hammel, Jeffrey
    Remzi, Feza
    Kiran, Ravi
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S2 - S3
  • [46] Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis
    Soetikno, RM
    Heidenreich, PA
    Young, HS
    Blackstone, MO
    GASTROENTEROLOGY, 1997, 112 (04) : A43 - A43
  • [47] Impact of Ulcerative Colitis on Patients With Primary Sclerosing Cholangitis With or Without Dominant Stricture
    Navaneethan, Udayakumar
    Venkatesh, Preethi G. K.
    Kochhar, Gursimran S.
    Lashner, Bret
    Sanaka, Madhusudhan R.
    Kiran, Pokala R.
    Shen, Bo
    GASTROENTEROLOGY, 2012, 142 (05) : S662 - S662
  • [48] Impact of Ulcerative Colitis on the Long Term Outcome of Patients With Primary Sclerosing Cholangitis
    Navaneethan, Udayakumar
    Venkatesh, Preethi Gk
    Mukewar, Saurabh
    Lashner, Bret
    Remzi, Feza H.
    Kiran, Pokala R.
    Shen, Bo
    Fung, John J.
    GASTROENTEROLOGY, 2012, 142 (05) : S8 - S8
  • [49] The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis
    Marchesa, P
    Lashner, BA
    Lavery, IC
    Milsom, J
    Hull, TL
    Strong, SA
    Church, JM
    Navarro, G
    Fazio, VW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (08): : 1285 - 1288
  • [50] Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis
    Fattahi, Mohammad Reza
    Malek-Hosseini, Seyyed Ali
    Sivandzadeh, Gholam Reza
    Safarpour, Ali Reza
    Lankarani, Kamran Bagheri
    Taghavi, Ali Reza
    Ejtehadi, Fardad
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) : 1160 - 1167